Top 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with a price target of $370, up from $220, after updating his 2022 sales estimates for quarterly trends ...
Source LinkTop 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with a price target of $370, up from $220, after updating his 2022 sales estimates for quarterly trends ...
Source Link
Comments